close 74% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Dashboard

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Strona główna・Stock List・WaVe Life Sciences Ltd
Search

WaVe Life Sciences Ltd

Closed

6.67 -11.42

Strong Buy

Price update 3 kwi 2025, 19:58 UTC

BuySell

Overview

Share price change

24h

Current

Min

6.6

Max

7.55

Key metrics

By Trading Economics

Income

91M

29M

Sales

91M

84M

EPS

0.27

Profit margin

34.93

Employees

287

EBITDA

87M

25M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+179.97% upside

Dividends

By Dow Jones

Next Earnings

8 maj 2025

Market Stats

By TradingEconomics

Market Cap

-210M

1.3B

Previous open

18.09

Previous close

6.67

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.43 Support & Resistance

WaVe Life Sciences Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 paź 2024, 15:56 UTC

Acquisitions, Mergers, Takeovers

GSK Bought More Shares of Biotech Wave Life Sciences -- Barrons.com

DJ

Read

20 cze 2024, 18:51 UTC

Earnings

Obesity-Drug Developers Look at What's Next for a $100 Billion Market -- Barrons.com

DJ

Read

Peer Comparison

Price change

WaVe Life Sciences Ltd Forecast

Price Target

By TipRanks

179.97% upside

12 Months Forecast

Average 21.67 USD  179.97%

High 26 USD

Low 14 USD

Based on 10 Wall Street analysts offering 12 month price targets forWaVe Life Sciences Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Based on 10 analysts giving stock ratings to WaVe Life Sciences Ltd - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.43Support & Resistance

Short Term

Bearish Evidence

Bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

87.86

↓-1.21%

VEEV

Veeva Systems Inc

221.66

↓-2.12%

A

Agilent Technologies Inc

109.71

↓-5.41%

HQY

HealthEquity Inc

82.88

↓-6.59%

PDCO

Patterson Cos Inc

31.2

↓-0.22%